NSAID users not at higher risk of death related to COVID-19

Reuters Health - 05/02/2021 - Despite concerns to the contrary, use of non-steroidal anti-inflammatory drugs (NSAIDs) is not associated with harmful effects or a higher mortality in patients with COVID-19, according to researchers in the U.K. "We showed that there is no evidence of a higher risk of COVID-19-related death associated with routine use of non-steroidal anti-inflammatory drugs," Dr. Angel Y. S. Wong of the London School of Hygiene and Tropical Medicine told Reuters Health by email. Nearly 11 million NSAID prescriptions for relief of pain and inflammation have been issued over the past 12 months in England, Dr. Wong and colleagues note in Annals of the Rheumatic Diseases. And many, including aspirin and ibuprofen, are available over the counter. However, based on unpublished reports of the effects of ibuprofen, French authorities recommended that NSAIDs be avoided in patients with COVID-19. This led to a directive by the U.K. National Health Servic...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on 5 February, 20219 February, 2021